Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

Can Cinderella save us?

PACE announces partnership with UKHSA to tackle antimicrobial resistance

AMR is designated by WHO as one of the top ten threats to global public health

- PMLiVE

Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes

Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.

Graphite Digital

- PMLiVE

Almirall gains rights to Novo Nordisk’s IL-21 blocker for dermatological diseases

NN-8828 has been developed up to phase 2 in non-dermatological indications

- PMLiVE

US study identifies over 275 million new genetic variants from NIH research programme

Researchers could use the findings to better understand the genetic influences on health and disease

- PMLiVE

Pfizer’s Velsipity granted EC approval for ulcerative colitis in patients aged from 16 years

The immune-mediated inflammatory bowel disease affects approximately 2.6 million people in Europe

- PMLiVE

Edelman appoints Jenni Mercer as UK head of healthcare marketing

Mercer joins the communications firm from Evoke, an Inizio company

- PMLiVE

performance.io propels global reach and sets sail in Japan

The agency has also welcomed Ted Makiyi as vice president, client relations Japan and Kay Shigemori as senior content manager

- PMLiVE

THE SECRET TO EFFECTIVE IMPACT MEASUREMENT IN DIGITAL MEDICAL EDUCATION

Moving away from 'vanity' metrics towards demonstrating real value for healthcare professionals and their patients, the time is right to evolve impact measurement in digital medical education.

EPG Health

- PMLiVE

Enhancing the patient–HCP relationship in rare diseases

By Maggie Lai

Amiculum

Healthcare professionals seek independent medical education (IME)

The evolving healthcare advertising landscape

Industry experts share their insights on the emerging trends in healthcare advertising

Wiley

HCP icons in Cuttsy+Cuttsy branded shapes

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Cuttsy + Cuttsy

- PMLiVE

AstraZeneca’s Tagrisso combination approved by FDA for advanced lung cancer

An estimated 200,000 people in the US are diagnosed with lung cancer every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links